	Early, delayed, or combined contrast-enhanced mammography for detecting residual disease after neoadjuvant chemotherapy in breast cancer. Eur Radiol Bellini C, Bicchierai G, Maiello C, Amato F, de Benedetto D, di Naro F, Vidali S, Tonelli P, Vanzi E, Boeri C, Visani L, Vezzosi V, Orzalesi L, Susini T, Miele V, Nori J. PMID: 42141291 [PubMed - as supplied by publisher]
	Study on the synergistic efficacy and mechanism of CD24 silencing combined with trastuzumab in HER2-positive breast cancer. J Mol Histol Lu Y, Zhou X, Gao Y, Zhu Z, Deng B, Lv W, Fu Z, Ding H, Zhong L. PMID: 42141178 [PubMed - indexed for MEDLINE]
	Feasibility study of the Four-Session Cognitive-Behavioral Therapy-based Psychological Intervention Program for women with HER2-positive metastatic breast cancer. Support Care Cancer Szekeres T, Balázs MÁ, Madarász B, Póti Z, Urbán R, Dank M, Vizin G. PMID: 42141145 [PubMed - indexed for MEDLINE]
	Expert recommendations for PIK3CA testing in HR+/HER2- locally advanced and metastatic breast cancer. NPJ Breast Cancer Marchiò C, Rojo F, Copson ER, Schmitt F, Bellosillo B, Fremd C. PMID: 42140989 [PubMed - as supplied by publisher]
	Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial. Nat Commun Garrido-Castro AC, Graham N, Li KX, Bi L, Crowdis J, Bi K, Park J, Pastorello R, Li Y, Gupta H, Kuntz T, Petry R, Pasquina LW, Patel A, Lange P, DiLullo M, Attaya V, Frey AM, Childress MA, Wesolowski R, Sinclair N, Sinclair S, Lo S, Tung N, Faggen M, Kaufman PA, Block CC, Walsh J, Toke M, Chen W, Wucherpfennig KW, Tian Y, Williams AJ, Mukhopadhyay S, Dasgupta T, Schnitt S, Cherniack AD, Barroso R, Ligibel J, Lin NU, Mittendorf EA, Tayob N, Van Allen E, Tolaney SM. PMID: 42140950 [PubMed - as supplied by publisher]
	Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights. NPJ Breast Cancer Aloss K, Frederick MI, Hassan S. PMID: 42140928 [PubMed - as supplied by publisher]
	FIMBRIMENOP-2402 trial: evaluating fimbriectomy with delayed oophorectomy in patients with high-risk tubo-ovarian cancer. Int J Gynecol Cancer Schoenen S, Mailliez A, Risbourg S, Decoupigny E, Vanseymortier M, Pasquesoone C, Le Saux O, Ray-Coquard I, Navarro AS, Bresson L, Thiebaut A, Antoni G, Bertrand N, Leblanc E, Narducci F, Le Deley MC, Martinez Gomez C. PMID: 42140840 [PubMed - as supplied by publisher]
	A randomized, open-label phase II non-inferiority study of niraparib maintenance after 3 versus 6 cycles of platinum-based chemotherapy in patients with completely debulked advanced HRD-positive high-grade ovarian cancer in first-line therapy (N-PLUS/NOGGO-ov53/ENGOT-ov62). Int J Gynecol Cancer Sehouli J, Pietzner K, Zocholl D, Nguyen J, Leitner K, Eichbaum M, Goldmann J, Frühauf F, Van Gorp T, Estévez-García P, Katsaros D, Braicu EI. PMID: 42140839 [PubMed - as supplied by publisher]
	Bidirectional association between breast cancer and cardiovascular disease: Longitudinal analysis of UK Biobank data. Atherosclerosis Liu Z, Du F, Zhao C, Xu C, Fu Z, Fan Y, Zhang B, Huang X, Lu Z, Jiang F, Huang Y, Guo X, Ma J. PMID: 42140725 [PubMed - indexed for MEDLINE]
	The Role of Health Literacy in Breast Cancer Treatment and Outcomes. J Natl Compr Canc Netw Bradley EM, Woodhouse P, Moses KA, Salwei ME, Sexton KW, Kripalani S, McCaffery RL, Idrees K. PMID: 42140267 [PubMed - indexed for MEDLINE]
	Navigating the future: An updated review and prospects for breast cancer vaccines. Int Immunopharmacol Roslei ASM, Huri HZ, Fisol FA, Nawaz A, Pratama DAOA, Sofian ZM, Jalil MFA, Nordin AH, Haron DEM, Norpi ASM, Azemi AK, Nordin ML. PMID: 42140162 [PubMed - as supplied by publisher]
	Preoperative hypoalbuminemia and survival among patients selected for primary cytoreduction in advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study. Gynecol Oncol Finch L, Dagher C, Harlev C, Finlan M, Kahn RM, Yeoshoua E, Iasonos A, Zhou Q, Broach V, Long KC, Gardner GJ, Sonoda Y, Abu-Rustum NR, Chi DS. PMID: 42139818 [PubMed - as supplied by publisher]
	Cervical pathology: Diagnosis, treatment and management of patients with Human Papillomavirus. Wiad Lek Smiianov VV, Fartushok TV, Semenyna HB, Fartushok NV. PMID: 42139626 [PubMed - indexed for MEDLINE]
	Prognostic factors for breast cancer progression. Wiad Lek Chuprovska Y, Bodiaka V, Ivashchuk O, Morar I. PMID: 42139613 [PubMed - indexed for MEDLINE]
	Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India. PLoS One Mukherjee A, Goyal P, Tripathi R, Goyal S, Batra U, Talwar V, Goel V, Jain A, Saha S, Bothra S, Agrawal C, Chugh S, Doval DC. PMID: 42139194 [PubMed - indexed for MEDLINE]
	Clitoral reconstructive surgery in patients with vulvar (pre)malignancies: what can we learn from female genital mutilation/cutting? A scoping review. Sex Med Rev Veldmate G, Ebisch RMF, Cornel K, Nijhuis T, de Hullu JA, Ten Eikelder MLG. PMID: 42139167 [PubMed - indexed for MEDLINE]
	The discriminative role of angiopoietin-like protein-3 for metabolic syndrome in polycystic ovary syndrome. Rev Assoc Med Bras (1992) Karaca ÖA, Ozgen G, Dogan O, Dincgez B, Ozgen L. PMID: 42138933 [PubMed - indexed for MEDLINE]
	Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years. JAMA Netw Open Spencer JC, Montealegre JR, Calderón-Mora J, Pignone MP. PMID: 42138919 [PubMed - indexed for MEDLINE]
	Reduced bone turnover in non-obese women with polycystic ovary syndrome: a cross-sectional study on procollagen-1 N-terminal peptide and beta-C terminal telopeptide. Rev Assoc Med Bras (1992) Kirlangic MM, Sahin E, Sahin ME, Yalman MV, Akdemir E, , Kutuk S. PMID: 42138865 [PubMed - indexed for MEDLINE]
	From tumor microenvironment orchestrators to actionable targets: a systematic review of TAM-targeted therapies in triple-negative breast cancer. Int J Clin Oncol Pei Y, Zhang J, Li C, Wang Y, Yu Q, Chen W. PMID: 42138756 [PubMed - as supplied by publisher]

Articles 1 - 20 / 328742

Page 1 of 16438



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy